Stock ABVC ABVC BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus ABVC BioPharma, Inc.

Equities

ABVC

US00091F3047

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
1.42 USD -10.69% Intraday chart for ABVC BioPharma, Inc. +43.42% +22.41%
Apr. 10 ABVC BioPharma, Inc., BioLite, Inc. and Rgene Corporation Enter Term Sheet with OncoX BioPharma, Inc CI
Mar. 26 ABVC BioPharma, Inc. and BioFirst Corporation Enter Global Licensing Agreement with ForSeeCon Eye Corporation CI

Evolution of the average Target Price on ABVC BioPharma, Inc.

Price target over the last 5 years

History of analyst recommendation changes

306c766a5aa5.62MgNl5FEp-tkUMM4Tivp5qdhnv_IHuR-ZAkRx3X4G8.hDUURg4vYa_CqDpIqEvu78zl1COgcDLCq9pdCHKRoVa4FxdcJHQh95joGg~1772cd58fe5d8f4f4d4411123d2713ca

Analyst Recommendations on ABVC BioPharma, Inc.

Wall Street Set to Open Lower as Investors Await Fed Rate Hike MT
Maxim Downgrades ABVC Biopharma to Hold From Buy MT
Maxim Initiates Coverage on Abvc BioPharma With Buy Rating, $3 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1.42
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering ABVC BioPharma, Inc.

Maxim

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ABVC Stock
  4. Consensus ABVC BioPharma, Inc.